Enbrel

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court
Fierce Pharma
Tue, 03/26/24 - 04:31 pm
Amgen
Enbrel
Medicare
Colorado
drug pricing
Colorado could cap payments for Amgen’s Enbrel
Stat
Thu, 02/22/24 - 11:47 am
Colorado
Amgen
autoimmune disease
Enbrel
reimbursement
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year
Fierce Pharma
Wed, 12/1/21 - 10:14 am
Amgen
Enbrel
Samsung
biosimilars
patents
A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug
BioPharma Dive
Mon, 11/1/21 - 11:56 am
Amgen
Enbrel
rheumatoid arthritis
patents
Pandemic slowed sales of cancer, arthritis, diabetes drugs
Beckers Hospital Review
Mon, 05/3/21 - 10:48 am
COVID-19
pandemic
cancer
diabetes
arthritis
Merck
Keytruda
Amgen
Enbrel
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Fierce Pharma
Wed, 07/8/20 - 11:58 pm
Amgen
clinical trials
COVID-19
anti-TNF
Enbrel
Bob Bradway
Pharma CEOs
Amgen's Enbrel Patents to Be Upheld Through 2029
Motley Fool
Thu, 07/2/20 - 12:15 am
psoriasis
rheumatoid arthritis
Enbrel
Novartis
biosimilars
patents
Amgen snags another Enbrel outcomes-based payment deal as it seeks to prop up aging blockbuster
Fierce Pharma
Wed, 12/4/19 - 11:18 pm
Amgen
Enbrel
Abarca
PBMs
rheumatoid arthritis
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Amgen
Otezla
Enbrel
drug reps
M&A
Celgene
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Sat, 08/17/19 - 01:38 pm
Amgen
Enbrel
patents
biologics
Advair
Zantac
Liptor
Plavix
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
What Enbrel needs to do after its patent win
EP Vantage
Mon, 08/12/19 - 11:48 am
Amgen
Enbrel
patents
generics
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Amgen
Enbrel
patents
Sandoz
generics
A Missed Alzheimer’s Opportunity? Not So Much
In the Pipeline
Thu, 06/6/19 - 01:17 pm
Pfizer
Enbrel
Alzheimer's disease
social media
clinical trials
journalism
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
Washington Post, DC
Wed, 06/5/19 - 01:00 pm
Pfizer
Enbrel
Alzheimer's disease
FDA Approves 19th Biosimilar, 2nd for Enbrel
RAPS.org
Fri, 04/26/19 - 07:38 pm
FDA
Samsung Bioepis
Eticovo
biosimilars
Amgen
Enbrel
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
Amgen's top-selling Enbrel in balance as key court ruling nears
Biopharma Dive
Wed, 03/13/19 - 04:32 pm
Amgen
patents
Enbrel
biosimilars

Pages